Search Results 301-310 of 16543 for ������������KA���:ZA31���24������ ���������������������������������

  1. A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression - Mayo Clinic

    Rochester, Minnesota: 24-000337. NCT ID ... Eligibility last updated 10/24/23. Questions ... Barbara A; Tanaka KE. Kumiko E; Chiang DY. Derek ...

  2. ... 24,24, 300000000,HC 2D6 SEQUENCING,548,548, 300000002,HC 5-HTT GENE ANALYSIS,338,338, 300000004,HC ABL1 KD VARIANTS,705,850, 300000005,HC ACADS KNOWN ...

  3. Publications - Corrie R. Bach, M.D. - Mayo Clinic

    Nathoo N, Uhm JH, Porter AB, Hammack J, Jaeckle KA, Mrugala MM, Crum BA, Flanagan EP, Pittock SJ, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge ...

  4. ADJUSTING SIGNIFICANCE LMELS IN CENSORED DATA WHEN USING MULTIPLE TESTS SIMULTANEOUSLY by THOMAS R. FLE!YING and DAVID P. YARRIN

    the set of c distinct ordered observed censorship times in the pooled sample. +I. = 1. D,(c)-1 ! tjct k=o. INi(kI-1. ,. -1 where 1 f(k) = 0 for any f k=O. *. Li ...

  5. Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer - Mayo Clinic

    ... 24 consecutive months (ie, has had menses at any time during the preceding 24 consecutive months) must: Agree in writing to use, and be able to comply with ...

  6. Publications - Zeying Du, M.D., Ph.D. - Mayo Clinic

    2007 Oct; 59 (10):779-92 Epub 2007 July 24. View ... Shen Li Ke Xue Jin Zhan. 1999; 30(3):242-245 ... Shen Li Ke Xue Jin Zhan. 1998; 29(3):253-256 ...

  7. T2 Lens Study - Clinical Trials

    Rochester, Minnesota: 24-007058. About this study. The purpose of this study is to Estimation of metabolic parameters related to meal-absorption, insulin ...

  8. AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke - Mayo Clinic

    All patients must undergo electrocardiogram, transthoracic or transesophageal echocardiography (TTE or TEE) and at least 24 hours of cardiac rhythm monitoring ( ...

  9. Addressing Overdiagnosis in Thyroid Cancer - Mayo Clinic

    Rochester, Minnesota: 24-003980. About this study. The purpose of this study is to develop a radiological multivariate model to distinguish between malignant ...

  10. A Study of AFP464 for Treating Patients with Solid Tumors that are Metastatic or Resistant to Treatment, and Cannot Be Removed By Surgery - Mayo Clinic

    ... 24 +/- 4 hours following the end of AFP-464 infusion; International normalized ratio (INR) ≤ 1.4; If taking aspirin, must discontinue ≥ 5 days prior to ...